SUMMIT DETAILS
Earlier this year, we regrettably had to cancel the USA Summit in Washington and then the November Summit in London, due to Covid restrictions.
While it isn’t possible to welcome you in person, transitioning the Summit event online has given us the opportunity to create an event without geographical borders, combining the most compelling content on the science, evidence, policy and public health from an unparalleled line up of the leading scientists and researchers from across the globe.
We are delighted to publish the full agenda for The Virtual E-Cigarette Summit which will take place December 3-4. While we would ideally love for everyone to be able to join us for the live event, we appreciate that multiple time zones and challenging schedules means that joining the Summit for the duration in real time may be difficult, so we have designed the agenda to work as individual sessions which can be viewed on demand from December 1st. The Panel Debates and Q&A sessions will be live during their scheduled times (See Agenda) but you will have the opportunity to pose questions in advance and watch back later.
We hope that the Virtual Summit will provide a welcoming focal point to grapple with the challenging questions posed by e-cigarettes and new novel nicotine products. Although Covid, Brexit and the US Presidential Election dominate our news media, there is a considerable amount of change happening in the public health, policy and regulatory environments related to tobacco, e-cigarettes and harm reduction.
For decades, the known harms from smoking and combustible products has aligned public health and tobacco control colleagues behind a known “enemy”. The emergence of less harmful alternatives has resulted in a heated debate that continues to divide scientists, health professionals and policy makers alike. The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the latest research and exploring how the evidence should be interpreted, to deliver the most effective health strategies to reduce smoking related death and disease. We hope that you can join us.
SUMMIT CHAIRS 2020
Prof Ann McNeill
Professor of Tobacco Addiction,
Kings College London
Prof Ann McNeill, Professor of Tobacco Addiction & Vice Dean, Kings College London
Martin Dockrell
Tobacco Control Programme Lead,
Public Health England
Martin Dockrell, Tobacco Control Programme Lead, PHE
Prof Robert West
Emeritus Professor of Health Psychology, University College London
Prof Robert West, Emeritus Professor of Health Psychology, University College London
Prof Thomas Glynn
Stanford University School of Medicine
Prof Thomas J. Glynn
Adjunct Lecturer, Stanford University School of Medicine
CONFIRMED SUMMIT SPEAKERS 2020
Paul Lincoln OBE
Chair - Tobacco: preventing uptake, promoting quitting and treating tobacco dependence
(NICE) National Institute of Clinical and Health Excellence -
Dr Colin Mendelsohn MB BS (Hons)
General practitioner, Founding Chairman
Australian Tobacco Harm Reduction Association
Nicky Coote
Service Lead & Specialist Smoking Cessation Practitioner
Barnet Stop Smoking Service, Public Health
Dr Jasjit S. Ahluwalia
Physician and Professor
Brown University School of Public Health and Alpert Medical School
Prof Daniel Kotz
Professor in addiction research and clinical epidemiology, Institute of General Practice
Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Germany
Prof Lion Shahab
Professor of Health Psychology, University College London
Co-Director of the UCL Tobacco and Alcohol Research Group
Prof Linda Bauld, OBE
Bruce and John Usher Chair in Public Health in the Usher Institute
College of Medicine, University of Edinburgh
Dr Michael Pesko
Health Economist & Associate Professor
Department of Economics, Andrew Young School of Policy Studies, Georgia State University
Dr Sharifa Ezat Wan Puteh
Professor of Hospital Management and Health Economics and Deputy Dean (Relation & Wealth Creation)
Faculty of Medicine, UKM Medical Centre
Prof Tikki Pang
Former Director, Research, Policy & Cooperation, World Health Organization
Geneva, Switzerland
Andrea Crossfield MBE
Independent Public Health Consultant and Population Health Policy Specialist
Greater Manchester Health and Social Care Partnership
Associate Prof Sivakumar Thurairajasingam
Associate Professor in Psychiatry
Head of the Clinical School Johor Bahru, Monash University Malaysia
Prof Alan Boobis, OBE
Emeritus Professor of Toxicology & Chair - UK Committee on Toxicity
Imperial College London
Prof Ann McNeill
Professor of Tobacco Addiction
Institute of Psychiatry, Psychology & Neuroscience, King's College London
Eve Taylor MSc
PHD Student and Research Assistant - Nicotine Research Group
King's College London (KCL)
Prof Virginia Berridge
Professor of History and Health Policy, Centre for History in Public Health
London School of Hygiene & Tropical Medicine, London, UK
Kate Pike
Co-ordinator - Trading Standards North West
Member of the Department of Health and Social Care National Tobacco Focus Group
Craig Copland
Head of E-Cigarettes, Healthcare, Quality and Access Group
MHRA - The Medicines and Healthcare products Regulatory Agency
Dr Debbie Robson RMN, PhD
Senior Lecturer in Tobacco Harm Reduction
National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London
Richard Holley
Area Manager (Smoking Cessation), Tobacco Control Lead
Northamptonshire Stop Smoking Service
Dr Jamie Hartmann-Boyce
Associate Professor and Editor Cochrane Tobacco Addiction Group
Nuffield Department of Primary Care Health Sciences, University of Oxford
Rosanna O’Connor
Director, Addictions & Inclusion
Office for Health Improvement & Disparities, Department of Health and Social Care
Prof John Newton, OBE FRCP FFPH FRSPH
Director of Public Health Analysis
Office for Health Improvement and Disparities (OHID)
Speaker TBC
Speaker to be confirmed
OHID
Dr Winston Price, M.D., FAAP, FACPE
Associate Professor
Philadelphia College of Osteopathic Medicine, CTIO-W. Montague Cobb/NMA Health Institute
Karl Fagerstrom
Professor Emeritus
President, Fagerstrom Consulting
Prof Geoffrey T. Fong, OC, Ph.D., FRSC, FCAHS
Founder and Chief Principal Investigator of the International Tobacco Control Policy Evaluation Project
Professor of Psychology and Public Health and Health Systems, University of Waterloo
Speaker TBC
Speaker to be confirmed
Regulator
Dr Ruth Sharrock
Clinical Lead for Tobacco Dependency for the North East & North Cumbria ICS
Respiratory Consultant, Queen Elizabeth Hospital - Gateshead
Prof Maciej L. Goniewicz
Professor of Oncology, Department of Health Behavior, Division of Cancer Prevention and Population Studies
Roswell Park Comprehensive Cancer Center
Ray Niaura
Interim Chair of Dep't of Epidemiology, Professor of Social and Behavioural Sciences
School of Global Public Health, New York University
Professor Marcus Munafò
Professor of Biological Psychology and MRC Investigator
School of Psychological Science, University of Bristol
Prof Thomas J. Glynn, PhD
Adjunct Lecturer
Stanford Prevention Research Center, Stanford University School of Medicine
Mitch Zeller, J.D
Director (Retired) Center for Tobacco Products (CTP)
The Food & Drug Administration (FDA)
Prof Wayne Hall
Professor Emeritus, National Centre for Youth Substance Use Research
The University of Queensland
Prof Martin Jarvis
Emeritus Professor of Health Psychology, Department of Behavioural Science & Health
University College London
Sarah Jackson
Principal Research Fellow Behavioural Science and Health
University College London (UCL)
Prof Sanjay Agrawal
Professor of Respiratory Science, Institute of Lung Health
University Hospitals of Leicester NHS Trust, Special Advisor on Tobacco, Royal College of Physicians
Prof Robert Beaglehole
Emeritus Professor
University of Auckland, New Zealand & Chair ASH - Action for Smokefree 2025, NZ
Prof Steven A. Schroeder, MD
Distinguished Professor of Health and Healthcare
University of California, San Francisco & Director, Smoking Cessation Leadership Center
Prof Robin Mermelstein
Distinguished Professor of Psychology & Director, Institute for Health Research and Policy
University of Illinois, Chicago
Assistant Prof Jamie Hartmann-Boyce
Assistant Professor in Health Promotion and Policy
University of Massachusetts Amherst
Cliff Douglas JD
Director, Tobacco Research Network, Adjunct Professor, Dep't of Health Management and Policy
University of Michigan School of Public Health
Prof Kenneth Warner
Avedis Donabedian Distinguished University Professor Emeritus of Public Health and Dean Emeritus
University of Michigan School of Public Health
Prof Dorothy Hatsukami
Professor, Department of Psychiatry and Behavioral Sciences
University of Minnesota
Dr Konstantinos Farsalinos M.D
External Research Associate
University of Patras, Department of Public and Community Health, University of West Attica, Greece
Prof Peter Hajek
Director of the Health and Lifestyle Research Unit
Wolfson Institute of Population Health, Queen Mary University of London
KEY THEMES TO BE EXPLORED
The Virtual E-Cigarette Summit 2020 will provide an inclusive platform to explore the latest research and scientific evidence. The Summit will run across 2 days and will be broken down into 7 separate sessions with a live Q&A opportunity with the panel, after each session:
Day 1 – Thursday 3 December
- Session 1: Science, Evidence and Research
- Session 2: Nicotine and Policy
- Session 3: THR and Public Health Policy
Day 2 – Friday 4 December
- Session 4: Tobacco Control, Industry and Regulation
- Session 5: Working with Tobacco Harm Reduction
- Session 6: Tobacco and Health Inequalities
- Session 7: Tobacco Control and THR
Keynote and closing address – Tobacco Control, Harm Reduction, and Science: Integrity is our most Important Asset
WHO SHOULD ATTEND
In particular, this event will be relevant to:
- Regulators and policy/government advisors
- Scientific/academic research community
- Clinical Commissioning Groups/PCT’s
- Smoking cessation practitioners/services
- Health charities and health campaigners
- Public health professionals
- Medical/health practitioners
- Industry and other stakeholders
The Summit independently provides hosted places for vapers and individuals without funding to attend. These places are discretionary and are considered on a case by case basis. If you would like to find out more please email info@smooth-events.com
WHO SHOULD ATTEND
- Regulators and policy/government advisors
- Scientific/research community
- Smoking cessation practitioners/services
- Health charities and health campaigners
- Public health professionals and academics
- Medical and health practitioners
- Industry and other stakeholders
The Summit independently provides hosted places for vapers and individuals without funding to attend. These places are discretionary and are considered on a case by case basis. If you would like to find out more please contact us by email on info@smooth-events.com
